# Botulinum Toxin Type A (Botox) for the Treatment of Cervical Dystonia and Upper Thoracic Muscular Pain

> **NCT00178945** · PHASE1,PHASE2 · COMPLETED · sponsor: **Vanderbilt University** · enrollment: 20 (—)

## Conditions studied

- Refractory Cervicothoracic Myofascial Pain Syndrome (CMPS)
- Cervical Dystonia

## Interventions

- **DRUG:** Botulinum Toxin Type A

## Key facts

- **NCT ID:** NCT00178945
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** —
- **Final completion:** 2006-03
- **Target enrollment:** 20 (—)
- **Last updated:** 2016-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00178945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00178945, "Botulinum Toxin Type A (Botox) for the Treatment of Cervical Dystonia and Upper Thoracic Muscular Pain". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00178945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*